Related Experiment Video
Updated: May 6, 2026
04:34
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
1.9K
Insomnia: prevalence, consequences and effective treatment.
David Cunnington1, Moira F Junge, Antonio T Fernando
1Melbourne Sleep Disorders Centre, Melbourne, VIC, Australia. david.cunnington@msdc.com.au.
The Medical Journal of Australia
|October 22, 2013
Summary
Insomnia, a common sleep disorder, can increase risks for depression and hypertension. Chronic insomnia management prioritizes cognitive behavior therapy over medication for better long-term outcomes.
Area of Science:
- Sleep Medicine
- Clinical Psychology
Background:
- Insomnia is a prevalent condition with significant health implications, including elevated risks for depression and hypertension.
- Differentiating between acute and chronic insomnia is crucial for effective treatment planning.
Purpose of the Study:
- To outline distinct management strategies for acute versus chronic insomnia.
- To emphasize the primary role of non-pharmacological interventions for chronic insomnia.
Main Methods:
- Review of current literature on insomnia management.
- Analysis of treatment efficacy for different insomnia subtypes.
Main Results:
- Chronic insomnia typically involves persistent symptoms or cycles of relapse and remission, rarely remitting spontaneously.
- Cognitive behavior therapy is identified as the most effective non-drug strategy for chronic insomnia.
Conclusions:
- Non-drug strategies, particularly cognitive behavior therapy, are the cornerstone for managing chronic insomnia.
- Pharmacological interventions like hypnotics may serve as adjunctive treatments for patients with persistent chronic insomnia symptoms.
Related Concept Videos
01:27Insomnia
623
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
623
01:19Management of Insomnia
788
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
788
01:13Insufficient Sleep and Sleep Deprivation
1.4K
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
1.4K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
990
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
990
01:07Narcolepsy
902
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
902
01:17Sleepwalking and Sleep Talking
1.8K
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
1.8K